I.V. Dressing Market Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
I.V. dressings are essentially
transparent dressings that are utilised as secondary dressings as well as I.V.
sites or catheters to the insertion point. I.V. dressings permit the extra
moisture while preserving the moist environment needed for wound healing. They
also aid in preventing infection by obstructing germs and keeping the catheter
site dry and clean. I.V. is used to provide medications, fluids, blood
transfusions, and other operations to patients. Patients who require fluid
replacement, electrolyte balance, or who are physically weak or unconscious are
given it.
Over the forecast period, it is
anticipated that the prevalence of diseases such as catheter-related
bloodstream infections (CRBSI), central line associated bloodstream infections
(CLABSI), and other infections will fuel for IV
dressing market expansion. For instance, 30,000 CLABSI cases are
reported annually in the U.S., according to data from the National Healthcare
Safety Network's Bloodstream Infection Surveillance, which was published in
March 2018. An extended hospital stay due to a CLABSI infection might raise
patient financial burden and increase the risk of death.
Additionally, the International
Society for Infectious Diseases revealed in March 2018 that there are roughly
250,000 instances of blood stream infections reported annually in the United
States. Catheter-related bloodstream infections (CRBSI), which happen in
intensive care units, make up about 80,000 of these cases.
Comments
Post a Comment